ArticleCase reports in oncological medicine2025

Hypercalcemia as an Immune-Related Adverse Event in a Patient Receiving Nivolumab and Ipilimumab for Metastatic Melanoma: A Case Report.

Sam Plessers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.